Published in Proc Natl Acad Sci U S A on October 20, 2008
Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol (2010) 3.45
Streptococcus adherence and colonization. Microbiol Mol Biol Rev (2009) 2.83
Two group A streptococcal peptide pheromones act through opposing Rgg regulators to control biofilm development. PLoS Pathog (2011) 1.89
CovS simultaneously activates and inhibits the CovR-mediated repression of distinct subsets of group A Streptococcus virulence factor-encoding genes. Infect Immun (2009) 1.62
Cationic antimicrobial peptides promote microbial mutagenesis and pathoadaptation in chronic infections. PLoS Pathog (2014) 1.56
The group A Streptococcus small regulatory RNA FasX enhances streptokinase activity by increasing the stability of the ska mRNA transcript. Mol Microbiol (2010) 1.37
Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innate immune factors in the intestine. Microb Biotechnol (2010) 1.30
Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiol (2009) 1.27
CcpA and LacD.1 affect temporal regulation of Streptococcus pyogenes virulence genes. Infect Immun (2009) 1.22
A combination of independent transcriptional regulators shapes bacterial virulence gene expression during infection. PLoS Pathog (2010) 1.10
Microevolution of group A streptococci in vivo: capturing regulatory networks engaged in sociomicrobiology, niche adaptation, and hypervirulence. PLoS One (2010) 1.09
Distinct single amino acid replacements in the control of virulence regulator protein differentially impact streptococcal pathogenesis. PLoS Pathog (2011) 1.07
Signal transduction through CsrRS confers an invasive phenotype in group A Streptococcus. PLoS Pathog (2011) 1.05
Streptolysin O and NAD-glycohydrolase prevent phagolysosome acidification and promote group A Streptococcus survival in macrophages. MBio (2014) 1.02
Antimicrobial peptides and their potential application in inflammation and sepsis. Crit Care (2012) 1.02
CsrRS regulates group B Streptococcus virulence gene expression in response to environmental pH: a new perspective on vaccine development. J Bacteriol (2009) 1.01
Human antimicrobial peptide LL-37 induces MefE/Mel-mediated macrolide resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother (2010) 0.94
Peroxide stimulon and role of PerR in group A Streptococcus. J Bacteriol (2011) 0.94
The 4.5S RNA component of the signal recognition particle is required for group A Streptococcus virulence. Microbiology (2010) 0.93
Focal targeting by human β-defensin 2 disrupts localized virulence factor assembly sites in Enterococcus faecalis. Proc Natl Acad Sci U S A (2013) 0.93
On the physiology and pathophysiology of antimicrobial peptides. Mol Med (2008) 0.93
Counteractive balancing of transcriptome expression involving CodY and CovRS in Streptococcus pyogenes. J Bacteriol (2011) 0.92
Cationic antimicrobial peptide resistance mechanisms of streptococcal pathogens. Biochim Biophys Acta (2015) 0.91
Bacterial Mg2+ homeostasis, transport, and virulence. Annu Rev Genet (2013) 0.91
Cationic antimicrobial peptides disrupt the Streptococcus pyogenes ExPortal. Mol Microbiol (2012) 0.89
The Abi-domain protein Abx1 interacts with the CovS histidine kinase to control virulence gene expression in group B Streptococcus. PLoS Pathog (2013) 0.88
A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptides. J Biol Chem (2012) 0.87
Thermoregulation of capsule production by Streptococcus pyogenes. PLoS One (2012) 0.85
Clindamycin-induced CovS-mediated regulation of the production of virulent exoproteins streptolysin O, NAD glycohydrolase, and streptokinase in Streptococcus pyogenes. Antimicrob Agents Chemother (2009) 0.84
Vitamin D and the human antimicrobial peptide LL-37 enhance group a streptococcus resistance to killing by human cells. MBio (2012) 0.83
Fluorescence and UV resonance Raman study of peptide-vesicle interactions of human cathelicidin LL-37 and its F6W and F17W mutants. Biochemistry (2009) 0.82
PepO, a CovRS-controlled endopeptidase, disrupts Streptococcus pyogenes quorum sensing. Mol Microbiol (2015) 0.82
Innate immune response to Streptococcus pyogenes depends on the combined activation of TLR13 and TLR2. PLoS One (2015) 0.80
The human antimicrobial peptide LL-37 binds directly to CsrS, a sensor histidine kinase of group A Streptococcus, to activate expression of virulence factors. J Biol Chem (2014) 0.79
Regioselective Benzylation of 2-Deoxy-2-Aminosugars Using Crown Ethers: Application to a Shortened Synthesis of Hyaluronic Acid Oligomers. Adv Synth Catal (2014) 0.78
Characterization of Mucoid and Non-Mucoid Streptococcus pneumoniae Isolated From Outpatients. Ann Lab Med (2015) 0.78
Host Antimicrobial Peptides in Bacterial Homeostasis and Pathogenesis of Disease. Antibiotics (Basel) (2014) 0.78
Wiring the streptococcal network for alternative lifestyles. J Infect Dis (2010) 0.78
On the role of NMR spectroscopy for characterization of antimicrobial peptides. Methods Mol Biol (2013) 0.77
The Transcriptional Regulator CpsY Is Important for Innate Immune Evasion in Streptococcus pyogenes. Infect Immun (2017) 0.75
Streptococcus pyogenes Endopeptidase O Contributes to Evasion from Complement-mediated Bacteriolysis via Binding to Human Complement Factor C1q. J Biol Chem (2017) 0.75
Regulatory gene mutation: A driving force behind group A Streptococcus strain- and serotype-specific variation. Mol Microbiol (2016) 0.75
SpxA1 and SpxA2 Act Coordinately To Fine-Tune Stress Responses and Virulence in Streptococcus pyogenes. MBio (2017) 0.75
A Bioengineered Human Skin Tissue for the Treatment of Infected Wounds. Adv Wound Care (New Rochelle) (2012) 0.75
Proteome analysis of the hyaluronic acid-producing bacterium, Streptococcus zooepidemicus. Proteome Sci (2009) 0.75
RocA is an accessory protein to the virulence-regulating CovR/S two-component system in the group A Streptococcus. Infect Immun (2017) 0.75
Use of a Phosphorylation Site Mutant to Identify Distinct Modes of Gene Repression by the Control of Virulence Regulator (CovR) in Streptococcus pyogenes. J Bacteriol (2017) 0.75
Chloramphenicol acetyltransferase from chloramphenicol-resistant bacteria. Methods Enzymol (1975) 16.73
Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature (2001) 6.71
Peptide antimicrobial agents. Clin Microbiol Rev (2006) 6.04
Invasive group A streptococcus infections. Clin Infect Dis (1992) 4.82
Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell (2005) 4.78
Streptococcal infections of skin and soft tissues. N Engl J Med (1996) 4.78
Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell (1998) 4.42
Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med (2001) 4.09
Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol Microbiol (1998) 3.84
Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc Natl Acad Sci U S A (2002) 3.83
Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog (2006) 3.68
Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci U S A (1991) 3.60
Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol (2001) 3.39
Regulation of bacterial virulence by two-component systems. Curr Opin Microbiol (2006) 2.81
IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J (2002) 2.77
C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun (1996) 2.77
Roles of the highly conserved aspartate and lysine residues in the response regulator of bacterial chemotaxis. J Biol Chem (1991) 2.58
Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Infect Dis (2001) 2.51
The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol (2007) 2.45
Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem (1997) 2.38
Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci U S A (2007) 2.34
Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci U S A (2003) 2.32
Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. Mol Microbiol (2003) 2.01
CovS inactivates CovR and is required for growth under conditions of general stress in Streptococcus pyogenes. J Bacteriol (2004) 2.00
Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J Infect Dis (2005) 1.91
Cathelicidins: a family of endogenous antimicrobial peptides. Curr Opin Hematol (2002) 1.86
Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proc Natl Acad Sci U S A (1994) 1.85
Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect Immun (1996) 1.79
Group A Streptococcus tissue invasion by CD44-mediated cell signalling. Nature (2001) 1.76
Perplexity and precision in the diagnosis of streptococcal pharyngitis. Am J Dis Child (1972) 1.72
A streptococcal protease that degrades CXC chemokines and impairs bacterial clearance from infected tissues. EMBO J (2006) 1.69
Characterization of the bacterial sensor protein PhoQ. Evidence for distinct binding sites for Mg2+ and Ca2+. J Biol Chem (1997) 1.68
The CsrR/CsrS two-component system of group A Streptococcus responds to environmental Mg2+. Proc Natl Acad Sci U S A (2003) 1.65
Synthesis and characterization of human alpha-defensins 4-6. J Pept Res (2004) 1.54
SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes. FEBS Lett (1999) 1.51
Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol (2002) 1.47
The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Mol Microbiol (2006) 1.46
Mg(2+) signalling defines the group A streptococcal CsrRS (CovRS) regulon. Mol Microbiol (2007) 1.31
Structure of the has operon promoter and regulation of hyaluronic acid capsule expression in group A Streptococcus. Mol Microbiol (1998) 1.30
M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns. J Clin Microbiol (2005) 1.27
Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans. Infect Immun (2008) 1.21
Salivary antimicrobial peptide expression and dental caries experience in children. Antimicrob Agents Chemother (2005) 1.19
Productive folding of human neutrophil alpha-defensins in vitro without the pro-peptide. J Am Chem Soc (2003) 1.18
Characterization of a mouse-passaged, highly encapsulated variant of group A streptococcus in in vitro and in vivo studies. J Infect Dis (2000) 1.17
Contribution of CsrR-regulated virulence factors to the progress and outcome of murine skin infections by Streptococcus pyogenes. Infect Immun (2004) 1.16
Opsonophagocytosis-inhibiting mac protein of group a streptococcus: identification and characteristics of two genetic complexes. Infect Immun (2002) 1.16
Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. Protein Eng (2002) 1.14
Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64. Infect Immun (2000) 1.13
Use of DNA arrays to identify a mutation in the negative regulator, csrR, responsible for the high virulence of a naturally occurring type M3 group A streptococcus clinical isolate. J Infect Dis (2006) 1.12
Burden of acute sore throat and group A streptococcal pharyngitis in school-aged children and their families in Australia. Pediatrics (2007) 1.11
RscA, a member of the MDR1 family of transporters, is repressed by CovR and required for growth of Streptococcus pyogenes under heat stress. J Bacteriol (2006) 1.10
Molecular recognition of bacterial phosphorelay proteins. Curr Opin Microbiol (2002) 1.05
RL-37, an alpha-helical antimicrobial peptide of the rhesus monkey. Antimicrob Agents Chemother (2001) 0.91
The intrinsic immunoglobulin g endopeptidase activity of streptococcal Mac-2 proteins implies a unique role for the enzymatically impaired Mac-2 protein of M28 serotype strains. Infect Immun (2008) 0.80
Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc Natl Acad Sci U S A (2005) 14.59
Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci U S A (2002) 5.28
Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci U S A (2003) 4.56
Structural and genetic diversity of group B streptococcus capsular polysaccharides. Infect Immun (2005) 2.51
Human α-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science (2012) 2.44
Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci U S A (2003) 2.32
Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. J Lipid Res (2008) 2.27
Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat Immunol (2005) 2.24
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature (2005) 2.23
Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc Natl Acad Sci U S A (2002) 2.14
Antibacterial activity and specificity of the six human {alpha}-defensins. Antimicrob Agents Chemother (2005) 2.11
α-Defensins in human innate immunity. Immunol Rev (2012) 2.10
Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX. Proc Natl Acad Sci U S A (2009) 1.94
The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J Immunol (2006) 1.94
Membrane-dependent oligomeric structure and pore formation of a beta-hairpin antimicrobial peptide in lipid bilayers from solid-state NMR. Proc Natl Acad Sci U S A (2006) 1.87
The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease. Infect Immun (2005) 1.86
Reawakening retrocyclins: ancestral human defensins active against HIV-1. PLoS Biol (2009) 1.80
Cystic lymphangioma of the jejunal mesentery in an adult: a case report. World J Gastroenterol (2005) 1.76
Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J Virol (2005) 1.75
Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells. Cell Host Microbe (2010) 1.71
Retrocyclin, an antiretroviral theta-defensin, is a lectin. J Immunol (2003) 1.69
Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci (2006) 1.68
NAD+-glycohydrolase acts as an intracellular toxin to enhance the extracellular survival of group A streptococci. Mol Microbiol (2002) 1.67
Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood (2006) 1.65
The CsrR/CsrS two-component system of group A Streptococcus responds to environmental Mg2+. Proc Natl Acad Sci U S A (2003) 1.65
Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection. J Immunol (2006) 1.64
Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob Agents Chemother (2003) 1.63
Interaction of antimicrobial peptide protegrin with biomembranes. Proc Natl Acad Sci U S A (2003) 1.61
Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo. Pediatr Res (2006) 1.59
Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virol (2004) 1.58
Solid-state NMR investigation of the depth of insertion of protegrin-1 in lipid bilayers using paramagnetic Mn2+. Biophys J (2003) 1.55
Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation. J Biol Chem (2006) 1.54
Solid-state NMR investigations of peptide-lipid interaction and orientation of a beta-sheet antimicrobial peptide, protegrin. Biochemistry (2002) 1.54
The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. J Biol Chem (2002) 1.53
Activity of alpha- and theta-defensins against primary isolates of HIV-1. J Immunol (2004) 1.50
Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A (2006) 1.48
Regulation of virulence by a two-component system in group B streptococcus. J Bacteriol (2005) 1.46
Preliminary experience of cetuximab in the treatment of advanced-stage biliary tract cancer. Onkologie (2010) 1.44
Evolution of primate theta-defensins: a serpentine path to a sweet tooth. Peptides (2003) 1.42
The theta-defensin, retrocyclin, inhibits HIV-1 entry. AIDS Res Hum Retroviruses (2003) 1.40
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids. J Lipid Res (2009) 1.37
Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides. J Mol Biol (2008) 1.37
Cytolysin-dependent evasion of lysosomal killing. Proc Natl Acad Sci U S A (2005) 1.35
Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog (2010) 1.34
Cytotoxic effects of streptolysin o and streptolysin s enhance the virulence of poorly encapsulated group a streptococci. Infect Immun (2003) 1.34
Mg(2+) signalling defines the group A streptococcal CsrRS (CovRS) regulon. Mol Microbiol (2007) 1.31
D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms. Proc Natl Acad Sci U S A (2010) 1.29
Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection. J Infect Dis (2005) 1.29
Toward understanding the cationicity of defensins. Arg and Lys versus their noncoded analogs. J Biol Chem (2007) 1.28
Synchronous double primary lung cancers via p53 pathway induced by heavy smoking. Ann Saudi Med (2010) 1.26
Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II. FEBS Lett (2010) 1.26
Through the looking glass, mechanistic insights from enantiomeric human defensins. J Biol Chem (2009) 1.25
Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids. J Biol Chem (2005) 1.25
Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. J Biol Chem (2006) 1.25
A novel role for defensins in intestinal homeostasis: regulation of IL-1beta secretion. J Immunol (2007) 1.23
Burden and economic cost of group A streptococcal pharyngitis. Pediatrics (2008) 1.23
RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates. AIDS Res Hum Retroviruses (2004) 1.23
Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D. J Immunol (2009) 1.22
Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins. J Immunol (2009) 1.21
Variation in the group B Streptococcus CsrRS regulon and effects on pathogenicity. J Bacteriol (2008) 1.21
Role of NADase in virulence in experimental invasive group A streptococcal infection. Infect Immun (2005) 1.20
Multivalent binding of carbohydrates by the human alpha-defensin, HD5. J Immunol (2009) 1.20
The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaques. PLoS One (2010) 1.19
Effects of guanidinium-phosphate hydrogen bonding on the membrane-bound structure and activity of an arginine-rich membrane peptide from solid-state NMR spectroscopy. Angew Chem Int Ed Engl (2008) 1.19
Enhancement of streptolysin O activity and intrinsic cytotoxic effects of the group A streptococcal toxin, NAD-glycohydrolase. J Biol Chem (2006) 1.18
Multifaceted mechanisms of HIV-1 entry inhibition by human α-defensin. J Biol Chem (2012) 1.18
Productive folding of human neutrophil alpha-defensins in vitro without the pro-peptide. J Am Chem Soc (2003) 1.18
Solid-state NMR investigation of the selective disruption of lipid membranes by protegrin-1. Biochemistry (2004) 1.18
Potassium release, a useful tool for studying antimicrobial peptides. J Microbiol Methods (2002) 1.18
HIV-1 adapts to a retrocyclin with cationic amino acid substitutions that reduce fusion efficiency of gp41. J Immunol (2006) 1.17
Why is the Arg5-Glu13 salt bridge conserved in mammalian alpha-defensins? J Biol Chem (2005) 1.17
The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability. J Biol Chem (2008) 1.16
Systematic mutational analysis of peptide inhibition of the p53-MDM2/MDMX interactions. J Mol Biol (2010) 1.16
Streptolysin O and its co-toxin NAD-glycohydrolase protect group A Streptococcus from Xenophagic killing. PLoS Pathog (2013) 1.16
Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission. J Immunol (2008) 1.15
Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. Protein Eng (2002) 1.14
alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s). J Infect Dis (2007) 1.14
Immobilization and aggregation of the antimicrobial peptide protegrin-1 in lipid bilayers investigated by solid-state NMR. Biochemistry (2003) 1.14
SMAP-29 has two LPS-binding sites and a central hinge. Eur J Biochem (2002) 1.13
Inhibition of pathologic retinal neovascularization by alpha-defensins. Blood (2005) 1.13
Inerolysin, a cholesterol-dependent cytolysin produced by Lactobacillus iners. J Bacteriol (2010) 1.13
Trp-26 imparts functional versatility to human alpha-defensin HNP1. J Biol Chem (2010) 1.12
Avian beta-defensin nomenclature: a community proposed update. Immunol Lett (2007) 1.12
Retrocyclin-2: structural analysis of a potent anti-HIV theta-defensin. Biochemistry (2007) 1.11
Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns. Antimicrob Agents Chemother (2002) 1.11
PerR confers phagocytic killing resistance and allows pharyngeal colonization by group A Streptococcus. PLoS Pathog (2008) 1.10
Turning a scorpion toxin into an antitumor miniprotein. J Am Chem Soc (2008) 1.10
Critical determinants of human α-defensin 5 activity against non-enveloped viruses. J Biol Chem (2012) 1.10
Role of predicted transmembrane domains for type III translocation, pore formation, and signaling by the Yersinia pseudotuberculosis YopB protein. Infect Immun (2005) 1.09
Extracellular group A Streptococcus induces keratinocyte apoptosis by dysregulating calcium signalling. Cell Microbiol (2005) 1.09
NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2. Antimicrob Agents Chemother (2003) 1.07
Structure-dependent functional properties of human defensin 5. FEBS Lett (2007) 1.07